InvestorsHub Logo
Followers 33
Posts 1917
Boards Moderated 1
Alias Born 08/02/2019

Re: loanranger post# 392182

Tuesday, 08/09/2022 8:32:34 PM

Tuesday, August 09, 2022 8:32:34 PM

Post# of 403044
""Then again you LR failed to say these facts- "certain patient subgroups did show treatment benefits of Brilacidin for that primary endpoint. For example, patients treated early from onset of symptoms achieved sustained recovery more quickly (Brilacidin 5-dose group vs pooled placebo, p=0.03)."

I did. And I was about to apologize when I saw that SS had posted a very relevant explanation that I hadn't even considered. I'll put it into my own words but first I wanted to remind you that neither I nor any other participant here has the OBLIGATION to provide the same fulsome scientific details that the authors of that paper had. I only feel an obligation to the truth....no more, no less."

But you did not complain that the authors did not include "fulsome scientific details" for example that one dose of Brilacidin killed MRSA the same as 7 day infusion of Daptomycin. Did they have an OBLIGATION to say Brilacidin is tested with success against oral mucositis? They said nothing on this. Do you complain that the authors did not give "fulsome scientific details" about the fulsome testing of Brilacidin against infectious viruses paid by the USA government? They also said nothing on this. So they are bad scientists with poor science? Pfft.

I only feel an obligation to the truth....no more, no less.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News